Technetium Tc-99m tilmanocept Completed Phase 1 Trials for NASH - Nonalcoholic Steatohepatitis / Nonalcoholic Steatohepatitis Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic1
clinicaltrials.gov IdentifierTitleDrugs
NCT03332940An Evaluation of the Safety of Intravenous Tc 99m Tilmanocept and a Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH